U2AF1 and lung adenocarcinoma: To identify potential downstream biological consequences of U2AF1 mutation, we performed a Gene Set Enrichment Analysis (GSEA) [15], [16] to identify gene sets positively correlated with the U2AF1 S34F/Y mutation in lung adenocarcinoma and in AML.